Salinomycin suppresses TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells

Chemico-Biological Interactions

Volumn 248, Issue , 2016, Pages 74-81

  Zhang, Chunying ^a   Lu, Ying ^a   Li, Qing ^a   Mao, Jun ^a   Hou, Zhenhuan ^a   Yu, Xiaotang ^a   Fan, Shujun ^a   Li, Jiazhi ^a   Gao, Tong ^a   Yan, Bing ^a   Wang, Bo ^a   Song, Bo ^a   Li, Lianhong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer MCF 7 cells; Epithelial to mesenchymal transition; Salinomycin; TGF Non Smad signaling; TGF Smad signaling

Indexed keywords

BETA CATENIN; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE P38; SALINOMYCIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; PYRAN DERIVATIVE; SMAD PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MCF 7 CELL LINE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR INVASION; WNT SIGNALING PATHWAY; BREAST TUMOR; CANCER STEM CELL; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; METASTASIS; SIGNAL TRANSDUCTION;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MCF-7 CELLS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PYRANS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84958983172     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2016.02.004     Document Type: Article

References (58)

1. A. Jemal, F. Bray, M.M. Center, and et al. Global cancer statistics CA Cancer J. Clin. 61 2 2011 69 90
2. T. Tsuji, S. Ibaragi, and G.F. Hu Epithelial-mesenchymal transition and cell cooperativity in metastasis Cancer Res. 69 18 2009 7135 7139
3. E. Sánchez-Tilló, Y. Liu, o de Barrios, and et al. EMT-activating transcription factor in cancer: beyond EMT and tumor invasiveness Cell Mol. Life Sci. 69 20 2012 3429 3456
4. C. Foroni, M. Broggini, D. Generali, and et al. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact Cancer Treat. Rev. 38 6 2012 689 697
5. D.J. Drasin, T.P. Robin, and H.L. Ford Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity Breast Cancer Res. 13 6 2011 226
6. A.G. de Herreros, S. Peiró, M. Nassour, and et al. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression J. Mammary Gland. Biol. Neoplasia 15 2 2010 135 147
7. A. Dhasarathy, D. Phadke, D. Mav, and et al. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer PLoS One 6 10 2011 e26514
8. J. Yang, S.A. Mani, J.L. Donaher, and et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 7 2004 927 939
9. S. Kotiyal, and S. Bhattacharya Breast cancer stem cells, EMT and therapeutic targets Biochem. Biophys. Res. Commun. 453 1 2014 112 116
10. R. Derynck, B.P. Muthusamy, and K.Y. Saeteurn Signaling pathway cooperation in TGF-b-induced epithelial-mesenchymal transition Curr. Opin. Cell Biol. 31 2014 56 66
11. N. Takebe, R.Q. Warren, and S.P. Ivy Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition Breast Cancer Res. 13 3 2011 211
12. C.H. Heldin, M. Landström, and A. Moustakas Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial transition Curr. Opin. Cell Biol. 21 2 2009 166 176
13. S. Lamouille, J. Xu, and R. Derynck Molecular mechanisms of epithelial-mesenchymal transition Nat. Rev. Mol. Cell Biol. 15 3 2014 178 196
14. X. Zhang, Y. Li, Y. Zhang, and et al. Beta-element blocks epithelial-mesenchymal transition in human breast cancer cell line MCF-7 through Smad3-mediated down-regulation of nuclear transcription factors PLoS One 8 3 2013 e58719
15. Y. Wang, and B.P. Zhou Epithelial-mesenchymal transition in breast cancer progression and metastasis Chin. J. Cancer 30 9 2011 603 611
16. D.M. Gonzalez, and D. Medici Signaling mechanisms of the epithelial-mesenchymal transition Sci. Signal 7 344 2014 re8
17. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 3 2006 469 480
18. J.I. Yook, X.Y. Li, I. Ota, and et al. A WNT-Axin2-GSK3beta cascade regulates snail1 activity in breast cancer cells Nat. Cell Biol. 8 12 2006 1398 1406
19. M. Bakkebø, K. Huse, V.I. Hilden, and et al. TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK BMC Immunol. 11 1 2010 57
20. R. Luciana, F. Letícia, A.M. Rosângela, and et al. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells BMC Cancer 12 2012 26
21. Y. Tan, Q. Xu, Y. Li, and et al. Crosstalk between the p38 and TGF-β signaling pathways through TβRI, TβRII and Smad3 expression in placental choriocarcinoma JEG-3 cells Oncol. Lett. 8 3 2014 1307 1311
22. J. Hong, J. Zhou, J. Fu, and et al. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness Cancer Res. 71 11 2011 3980 3990
23. C. Naujokat, and R. Steinhart Salinomycin as a drug for targeting human cancer stem cells J. Biomed. Biotechnol. 2012 950658 doi:10. 1155/2012/950658. Epub 2012 Nov 21
24. P.B. Gupta, T.T. Onder, G. Jiang, and et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 138 4 2009 645 659
25. S.Z. Kuo, K.J. Blair, E. Rahimy, and et al. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt BMC Cancer 12 2012 Nov 24 556 10.1186/1471-2407-12-556
26. T.T. Dong, H.M. Zhou, L.L. Wang, and et al. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines Ann. Surg. Oncol. 18 6 2011 1797 1804
27. S. Kusunoki, K. Kato, K. Tabu, and et al. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells Gynecol. Oncol. 129 3 2013 598 605
28. F. Wang, L. He, W.Q. Dai, and et al. Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo PloS One 7 12 2012 e50638
29. K. Ketola, M. Hilvo, T. Hyötyläinen, and et al. Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress Br. J. Cancer 106 1 2012 99 106
30. A. Scherzed, S. Hackenberg, K. Froelich, and et al. Effects of salinomycin on human bone marrow-derived mesenchymal stem cells in vitro Toxicol. Lett. 218 3 2013 207 214
31. L. Xu, T. Wang, W.Y. Meng, and et al. Salinomycin inhibits hepatocellular carcinoma cell invasion and migration through JNK/JunD pathway-mediated MMP9 expression Oncol. Rep. 33 3 2015 1057 1063
32. Y. Lu, W. Ma, J. Mao, and et al. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling Chem. Biol. Interact. 228 2015, Feb 25 100 107 10.1016/j.cbi.2014.12.002 Epub 2014 Dec 8
33. C. DeSantis, J. Ma, L. Bryan, and et al. Breast cancer statistics CA Cancer J. Clin. 64 1 2014 52 62
34. Kyeong-Nam Yu, Arash Minai-Tehrani, Seung-Hee Chang, and et al. Aerosol delivery of small hairpin osteopontin blocks pulmonary metastasis of breast cancer in mice PLoS One 5 12 2010 e15623
35. Leslie Ferrarelli, K. Gough, and R. Nancy Focus issue: TGF-beta and the mesenchymal transition in physiology and disease Sci. Signal 7 2014 eg3 10.1126/scisignal.2005909
36. J.L. Wrana Signaling by the TGF-β superfamily Cold Spring Harb. Perspect. Biol. 5 10 2013 a011197
37. H. Clevers, and R. Nusse Wnt/beta-catenin signaling and disease Cell 149 6 2012 1192 1205
38. N. Takebe, R.Q. Warren, and S.P. Ivy Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition Breast Cancer Res. 13 3 2011 211
39. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J. Clin. Invest 119 6 2009 1420 1428
40. M.A. Nieto Epithelial plasticity: a common theme in embryonic and cancer cells Science 342 6159 2013 1234850
41. R. Bill, and G. Christofori The relevance of EMT in breast cancer metastasis: correlation or causality 589 14 2015 1577 1587
42. H. Zheng, M. Shen, Y.L. Zha, and et al. PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis Cancer Cell 26 3 2014 358 373
43. V.G. Cooke, V.S. LeBleu, D. Keskin, and et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway Cancer Cell 21 1 2012 66 81
44. H. Peinado, D. Olmeda, and A. Cano Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype Nat. Rev. Cancer 7 6 2007 415 428
45. P. Papageorgis, A.W. Lambert, S. Ozturk, and et al. Smad signaling is required to maintain epigenetic silencing during breast cancer progression Cancer Res. 70 3 2010 968 978
46. F. Kopp, A. Hermawan, P.S. Oak, and et al. Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration Mol. Cancer 13 2014 Jan 27 16 10.1186/1476-4598-13-16
47. K. Arafat, R. Iratni, T. Takahashi, and et al. Inhibitory effects of Salinomycin on cell survival, colony growth, migration, and invasion of human non-small cell lung cancer A549 and LNM35: involvement of NAG-1 PLos One 8 6 2013 e66931
48. Z. Shang, Q. Cai, M. Zhang, and et al. A switch from CD44 + cell to EMT cell drives the metastasis of prostate cancer Oncotarget 6 2 2015 1202 1216
49. E. Sánchez-Tilló, L. Fanlo, L. Siles, and et al. The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma Cell Death Differ. 21 2 2014 247 257
50. G. Wang, W. Wang, J. Zhou, and et al. Correlation between telomerase activity and matrix metalloproteinases 2 expression in gastric cancer Cancer Biomark. 13 2013 21 28
51. Meilin Shi, Menghan Cao, Jun Song, and et al. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway Mol. Cancer 14 2015 66
52. S. Zhu, J. Zhang, F. Xu, and et al. IGFBP-rP1 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer Cell Death Dis. 6 2015 Mar 19 e1695 10.1038/cddis.2015.59
53. J. Kim, and S Hwan Kim CK2 Inhibitor CX-4945 Blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells PLoS One 8 9 2013 e74342
54. T.A. DiMeo, K. Anderson, P. Phadke, and et al. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer Cancer Res. 69 13 2009 5364 5373
55. A. Nawshad, D. Medici, C.C. Liu, and et al. TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex J. Cell Sci. 120 9 2007 1646 1653
56. W. Lu, and Y. Li Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells J. Cell Biochem. 115 10 2014 1799 1807
57. F. Wang, W. Dai, Y. Wang, and et al. The synergistic in vitro and in vivo antitumor effect of combination therapy with Salinomycin and 5-Fluorouracil against hepatocellular carcinoma PLoS One 9 5 2014 e97414
58. C.F. Woeller, C.W. O'Louqhlin, E. Roztocil, and et al. Salinomycin and other polyether ionophores are a new class of antiscarring agent J. Biol. Chem. 290 6 2015 3563 3575